OASIS® MICRO Micronized Wound Matrix is an advanced wound care product comprised of micronized extracellular matrix (ECM) from porcine small intestinal submucosa used to manage wounds. It is a three-dimensional extracellular matrix that retains the natural composition of matrix molecules, provides a scaffold for cellular invasion and capillary growth and maintains and supports a healing environment for wound management.
• Micronized formulation ensures the scaffold is in direct contact with the entire wound
• Stored at room temperature and simple to handle and manage with no advance preparation needed
• Contains components similar to those found in the human dermis
• Comes ready to apply
• Minimally processed and sterilized
• Long-term storage without compromising ability to support healing
• Naturally derived structure that supports healing process
• Incorporated and absorbed into the wound
OASIS® MICRO Micronized Wound Matrix is intended for the management of wounds including: partial- and full-thickness wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears), tunneled or undermined wounds, second-degree burns, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers and draining wounds.
OASIS® MICRO Micronized Wound Matrix is derived from a porcine source and should not be used in patients with known sensitivity to porcine material. OASIS® MICRO is not indicated for use in third-degree burns.
OASIS® MICRO Micronized Wound Matrix is designed for single use only. Attempts to reprocess, re-sterilize and/or reuse may lead to failure and/or transmission of disease.
Discard all open and unused portions of OASIS® MICRO Micronized Wound Matrix.
OASIS® MICRO Micronized Wound Matrix is sterile if the pouch is dry, unopened and undamaged. Do not use if the pouch seal is broken.
OASIS® MICRO Micronized Wound Matrix must be used prior to the expiration date.
Discard OASIS® MICRO Micronized Wound Matrix if mishandling has caused possible damage or contamination.
OASIS® MICRO Micronized Wound Matrix should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
The following complications are possible. Consider removing any residual product if any of these conditions occur:
Inflammation (Initial application of wound dressings may be associated with transient, mild, localized inflammation.)
This product should be stored in a clean, dry location at room temperature.
|Assigned HCPCS code|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for second-degree burns||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
Chronic Vascular Ulcers
Granulating/ Epithelializing Wounds
Non/Minimally Exudating Wounds
Partial- and Full-Thickness Wounds
Tunneled or Undermined Wounds
NOTE: Always handle OASIS® MICRO Micronized Wound Matrix using aseptic technique.
Prepare the wound bed using standard techniques. Apply OASIS® MICRO Micronized Wound Matrix by squeezing the bottle. The spout can be trimmed with scissors or the cap removed if a wider spout is preferred. Lightly cover as much of the wound as possible.
If needed, gently wet the application area with sterile saline to ensure OASIS® MICRO Micronized Wound Matrix is hydrated and adheres to the wound. Alternatively, a small amount of sterile saline can be mixed with the product in a sterile container to make a paste prior to application.
Apply a non-adherent dressing and secondary dressings.
Change secondary moisture-control dressings carefully as often as needed, but leave the non-adherent dressing in place until ready for re-application to prevent damage to the incorporating ECM.
Successful absorption may result in a caramel-colored gel. Do not remove the gel as it includes the incorporating ECM.
If desired, re-apply OASIS® MICRO Micronized Wound Matrix as needed, typically every three to seven days.
Apply a non-adherent primary wound dressing over OASIS® MICRO Micronized Wound Matrix. Assess the wound to determine moisture conditions and apply appropriate secondary dressing to maintain a moist wound environment.
Porcine small intestinal submucosa micronized product that comes in a squeeze bottle for ease of use.
For over 150 years, Smith+Nephew has taken a pioneering approach to product design and services, helping to reduce the human and economic costs of wounds.
Advanced Wound Bioactives
(Includes Collagenase SANTYL* Ointment, PROSHIELD* Foam & Spray Incontinent & Total Body Cleanser, PROSHIELD* Plus Skin Protectant, REGRANEX* (becaplermin) Gel 0.01%)
Toll-free: (800) 441-8227
Fax: (817) 900-4100
Cellular and/or Tissue-Based Products
(Includes GRAFIX PL*, GRAFIX*, STRAVIX*, OASIS® MICRO, OASIS® Wound Matrix, OASIS® Burn Matrix, and OASIS® Ultra Tri-Layer Matrix)
Phone: (888) 674-9551
Fax: (443) 283-4419
Advanced Wound Care or Devices
(Includes all other products listed below)
Toll-free: (800) 876-1261
Fax: (727) 392-6914
*Trademark of Smith+Nephew